Accordingly, recent reports investigating different treatment protocols showed conflicting data on post-treatment immune checkpoint protein expression in RC [36,37,38,39]; of note, a meta-analysis demonstrated general agreement on the association of PD-L1 protein expression with poor prognosis and on its applicability as a biomarker in CRC patients [40]. The gene discussed is CD274; the disease is colorectal carcinoma.